Detalhe da pesquisa
1.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214090
2.
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
Haematologica
; 107(12): 2859-2869, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615931
3.
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
Blood
; 129(7): 846-854, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932374
4.
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
Cancer
; 124(14): 2956-2963, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723417
5.
Blood transfusion in hematologic intensive care unit.
Transfusion
; 57(2): 296-302, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27861958
6.
Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question.
Br J Haematol
; 195(3): 469-471, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396510
7.
The prognostic value of hematogones in patients with acute myeloid leukemia.
Am J Hematol
; 91(6): 566-70, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26934680
8.
Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia.
Cancer
; 119(24): 4284-9, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105694
9.
ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia
Turk J Haematol
; 40(2): 101-117, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026766
10.
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Leuk Res
; 130: 107308, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230027
11.
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia.
Cancers (Basel)
; 14(19)2022 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230624
12.
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia.
Pharmaceutics
; 14(8)2022 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36015302
13.
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.
Leukemia
; 35(8): 2332-2345, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483613
14.
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients.
Clin Cancer Res
; 25(22): 6606-6613, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292142
15.
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
PLoS One
; 13(8): e0200923, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30091999
16.
Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma.
Leuk Lymphoma
; 59(1): 187-195, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28562153
17.
[Management of the cardiovascular disease risk during nilotinib treatment in chronic myeloid leukemia: 2015 recommendations from the France Intergroupe des Leucémies Myéloïdes Chroniques]. / Recommandations 2015 du France Intergroupe des Leucémies Myéloïdes Chroniques pour la gestion du risque d'événements cardiovasculaires sous nilotinib au cours de la leucémie myéloïde chronique.
Bull Cancer
; 103(2): 180-9, 2016 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-26790711
18.
Successful Imatinib therapy as a bridge to transplant in an atypical myeloproliferative neoplasm.
Curr Res Transl Med
; 67(4): 149-151, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31153956